Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
11/06/2026 06:33
BRIEF-Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan June 11 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS:
ASTRAZENECA PHARMA - RECEIVED PERMISSION TO IMPORT FOR SALE OF TRASTUZUMAB DERUXTECAN
Source text: ID:nBSE6vFWJS
Further company coverage: ASTR.NS
((reuters.briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan
India's Astrazeneca Pharma logs worst slide in two months on quarterly profit drop
Brief: Astrazeneca Pharma India March-Quarter PAT 448.8 Million Rupees
Brief: Astrazeneca Pharma India Recommends Dividend Of 36 Rupees Per Equity Share For Fy2025-26
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication